Adopting CDISC Standards: Our Journey With CDISC Blog Post
本ケーススタディでは、CDISCとの23年間のパートナーシップを探り、いくつかの共同プロジェクトを紹介します。
Regulatory Affairs Consulting Page
世界各国の薬事規制対応を成功に導くための戦略的ガイダンスとエンドツーエンドのサポートを提供し、前臨床から上市までの効率的かつコンプライアンスに準拠した医薬品開発を保証します。
Predict Success Faster in Drug Discovery – Designing a More Effective Model for Drug Discovery Research Blog Post
The average discovery phase of drug development lasts four and half years with just six percent of evaluated compounds moving into the preclinical development phase as candidates. Improving success rates…
Certara Completes Acquisition of Chemaxon Blog Post
The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through commercialization. RADNOR, PA., 2024年10月2日 — Certara, Inc. (Nasdaq:…
Certara Drug Development & Regulatory Experts Achieve 100th Rare Disease Submission Blog Post
Dedicated team of global regulatory experts drives the approval of rare disease treatments RADNOR, Pa. — 2024年10月1日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in model-informed drug…
A Quick Guide to SDTM Domains Blog Post
Our guide is a quick and thorough overview of SDTM domains, to help you implement the SDTM standard.
A Quick Guide to SDTM Dataset Creation Blog Post
Our free quick guide can help you better understand SDTM datasets and get started quick with SDTM dataset creation.
